![Muna Bhanji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Muna Bhanji
Direktor/Vorstandsmitglied bei
CYTOKINETICS, INCORPORATED
Vermögen: 5 Mio $ am 31.08.2026
Profil
Ms. Muna Bhanji is an Independent Director at Intellia Therapeutics, Inc., an Independent Director at Veracyte, Inc., an Independent Director at Ardelyx, Inc., an Independent Director at Cytokinetics, Inc., a Senior Advisor & Advisory Board Member at Arsenal Capital Management LP and a Principal at TIBA Global Access LLC.
She is on the Board of Directors at Intellia Therapeutics, Inc., Women Business Leaders of the US Health Care Industry Fnd, Womencorporatedirectors Foundation, Veracyte, Inc., Ardelyx, Inc., Cytokinetics, Inc., Corus International Ltd., Arsenal Capital Management LP, Lumanity, Inc. and Lumanity, Inc. (United States).
Ms. Bhanji was previously employed as a Senior VP-Global Market Access & Policy by Merck & Co., Inc. She also served on the board at AMCP Foundation, Nyaya Health, a Nonprofit Corp.
and Possible Health, Inc. She received her undergraduate degree from Ernest Mario School of Pharmacy and an MBA from St. Joseph's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 26’361 ( 0.02% ) | 2 Mio $ | 31.08.2026 | |
VERACYTE, INC. 0.05% | 01.09.2026 | 42’718 ( 0.05% ) | 2 Mio $ | 31.08.2026 |
ARDELYX, INC. 0.07% | 16.06.2026 | 163’808 ( 0.07% ) | 619 194 $ | 31.08.2026 |
| 09.06.2026 | 36’403 ( 0.03% ) | 463 410 $ | 31.08.2026 |
Aktive Positionen von Muna Bhanji
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Direktor/Vorstandsmitglied | 17.02.2021 |
| ARDELYX, INC. | Direktor/Vorstandsmitglied | 11.03.2021 |
| VERACYTE, INC. | Direktor/Vorstandsmitglied | 19.03.2021 |
| INTELLIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.04.2022 |
TIBA Global Access LLC | Gründer | 01.01.2021 |
Women Business Leaders of the US Health Care Industry Fnd | Direktor/Vorstandsmitglied | 01.05.2021 |
Womencorporatedirectors Foundation | Direktor/Vorstandsmitglied | 01.05.2021 |
Lumanity, Inc.
 Lumanity, Inc. Packaged SoftwareTechnology Services Develops AI based software solutions for healthcare and pharma industry | Direktor/Vorstandsmitglied | - |
Lumanity, Inc. (United States)
 Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Provides data transformation and analytics services | Direktor/Vorstandsmitglied | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Muna Bhanji
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Muna Bhanji
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Women Business Leaders of the US Health Care Industry Fnd | |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Corus International Ltd.
 Corus International Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
AMCP Foundation | |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Womencorporatedirectors Foundation | |
Possible Health
 Possible Health Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Commercial Services |
Possible Health, Inc.
 Possible Health, Inc. Internet Software/ServicesTechnology Services Provides online healthcare services | Technology Services |
TIBA Global Access LLC | |
Lumanity, Inc.
Lumanity, Inc. Packaged SoftwareTechnology Services Develops AI based software solutions for healthcare and pharma industry | Technology Services |
Lumanity, Inc. (United States)
Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Provides data transformation and analytics services | Technology Services |
